- Home
- MNDO vs DARE Comparison
MNDO vs DARE Comparison
Compare MNDO & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- DARE
- Stock Information
- Founded
- MNDO 1995
- DARE 2015
- Country
- MNDO Israel
- DARE United States
- Employees
- MNDO N/A
- DARE N/A
- Industry
- MNDO EDP Services
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- DARE Health Care
- Exchange
- MNDO Nasdaq
- DARE Nasdaq
- Market Cap
- MNDO 34.2M
- DARE 26.3M
- IPO Year
- MNDO 2000
- DARE N/A
- Fundamental
- Price
- MNDO $1.40
- DARE $2.37
- Analyst Decision
- MNDO
- DARE Strong Buy
- Analyst Count
- MNDO 0
- DARE 3
- Target Price
- MNDO N/A
- DARE $12.50
- AVG Volume (30 Days)
- MNDO 39.7K
- DARE 40.8K
- Earning Date
- MNDO 08-05-2025
- DARE 08-11-2025
- Dividend Yield
- MNDO 15.94%
- DARE N/A
- EPS Growth
- MNDO N/A
- DARE N/A
- EPS
- MNDO 0.17
- DARE N/A
- Revenue
- MNDO $20,677,000.00
- DARE $25,909.00
- Revenue This Year
- MNDO N/A
- DARE $99,756.91
- Revenue Next Year
- MNDO N/A
- DARE $119.77
- P/E Ratio
- MNDO $8.06
- DARE N/A
- Revenue Growth
- MNDO N/A
- DARE N/A
- 52 Week Low
- MNDO $1.31
- DARE $2.35
- 52 Week High
- MNDO $2.13
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- MNDO 47.83
- DARE 28.82
- Support Level
- MNDO $1.33
- DARE $2.35
- Resistance Level
- MNDO $1.37
- DARE $2.95
- Average True Range (ATR)
- MNDO 0.04
- DARE 0.12
- MACD
- MNDO 0.01
- DARE -0.07
- Stochastic Oscillator
- MNDO 55.88
- DARE 4.44
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.